These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23453973)

  • 1. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
    Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM
    Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.
    MacAulay K; Hajduch E; Blair AS; Coghlan MP; Smith SA; Hundal HS
    Eur J Biochem; 2003 Sep; 270(18):3829-38. PubMed ID: 12950267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons.
    Gil C; Chaib-Oukadour I; Aguilera J
    Biochem J; 2003 Jul; 373(Pt 2):613-20. PubMed ID: 12710887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
    Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
    J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells.
    MacAulay K; Blair AS; Hajduch E; Terashima T; Baba O; Sutherland C; Hundal HS
    J Biol Chem; 2005 Mar; 280(10):9509-18. PubMed ID: 15632169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.
    Wang X; Janmaat M; Beugnet A; Paulin FE; Proud CG
    Biochem J; 2002 Oct; 367(Pt 2):475-81. PubMed ID: 12133000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons.
    Hetman M; Hsuan SL; Habas A; Higgins MJ; Xia Z
    J Biol Chem; 2002 Dec; 277(51):49577-84. PubMed ID: 12393899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
    Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase 3B in bovine oocytes and granulosa cells: possible involvement in meiosis during in vitro maturation.
    Uzbekova S; Salhab M; Perreau C; Mermillod P; Dupont J
    Reproduction; 2009 Aug; 138(2):235-46. PubMed ID: 19470708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart.
    Mora A; Sakamoto K; McManus EJ; Alessi DR
    FEBS Lett; 2005 Jul; 579(17):3632-8. PubMed ID: 15961082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
    Lecat S; Belemnaba L; Galzi JL; Bucher B
    Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RO 31-8220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin.
    Standaert ML; Bandyopadhyay G; Antwi EK; Farese RV
    Endocrinology; 1999 May; 140(5):2145-51. PubMed ID: 10218965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner.
    Cale JM; Bird IM
    Biochem J; 2006 Sep; 398(2):279-88. PubMed ID: 16716148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and glycogenic effect of glycogen-targeting protein phosphatase 1 regulatory subunit GL in cultured human muscle.
    Montori-Grau M; Guitart M; Lerin C; Andreu AL; Newgard CB; García-Martínez C; Gómez-Foix AM
    Biochem J; 2007 Jul; 405(1):107-13. PubMed ID: 17555403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
    Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
    Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhibitors of mitogen-activated protein kinase kinase on alpha(1B)-adrenoceptor phosphorylation.
    Alcántara-Hernández R; Adolfo García-Sáinz J
    Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):13-23. PubMed ID: 19302552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.